[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2024, "totalPay": 571497, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2024, "totalPay": 223519, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2024, "totalPay": 391158, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 571579, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 2, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 9, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.01, "open": 1.01, "dayLow": 1.0, "dayHigh": 1.02, "regularMarketPreviousClose": 1.01, "regularMarketOpen": 1.01, "regularMarketDayLow": 1.0, "regularMarketDayHigh": 1.02, "payoutRatio": 0.0, "beta": 0.818, "forwardPE": -3.7279098, "volume": 273879, "regularMarketVolume": 273879, "averageVolume": 680739, "averageVolume10days": 522270, "averageDailyVolume10Day": 522270, "bid": 0.7488, "ask": 1.01, "bidSize": 2, "askSize": 1, "marketCap": 100997624, "fiftyTwoWeekLow": 0.771, "fiftyTwoWeekHigh": 1.59, "allTimeHigh": 10.0, "allTimeLow": 0.45, "fiftyDayAverage": 1.05408, "twoHundredDayAverage": 1.143185, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 76842072, "profitMargins": 0.0, "floatShares": 84421008, "sharesOutstanding": 99997648, "sharesShort": 1893967, "sharesShortPriorMonth": 1863417, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0189, "heldPercentInsiders": 0.03763, "heldPercentInstitutions": 0.11378, "shortRatio": 4.66, "shortPercentOfFloat": 0.0195, "impliedSharesOutstanding": 99997648, "bookValue": 0.07910239, "priceToBook": 12.768262, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -34784616, "trailingEps": -0.3, "forwardEps": -0.2709293, "enterpriseToEbitda": -2.111, "52WeekChange": -0.19199997, "SandP52WeekChange": 0.1340276, "quoteType": "EQUITY", "currentPrice": 1.01, "targetHighPrice": 9.110934, "targetLowPrice": 5.980726, "targetMeanPrice": 7.741106, "targetMedianPrice": 7.9363813, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 11622408, "totalCashPerShare": 0.133, "ebitda": -36409240, "totalDebt": 134199, "quickRatio": 3.593, "currentRatio": 3.893, "debtToEquity": 1.404, "returnOnAssets": -1.48826, "returnOnEquity": -3.4798098, "freeCashflow": -15344989, "operatingCashflow": -24222644, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1766192286, "regularMarketTime": 1766178002, "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.01, "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "postMarketChangePercent": 0.99009806, "postMarketPrice": 1.02, "postMarketChange": 0.00999999, "regularMarketChange": 0.0, "regularMarketDayRange": "1.0 - 1.02", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 680739, "fiftyTwoWeekLowChange": 0.23899996, "fiftyTwoWeekLowChangePercent": 0.30998698, "fiftyTwoWeekRange": "0.771 - 1.59", "fiftyTwoWeekHighChange": -0.58000004, "fiftyTwoWeekHighChangePercent": -0.3647799, "fiftyTwoWeekChangePercent": -19.199997, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.3, "epsForward": -0.2709293, "epsCurrentYear": -0.43, "priceEpsCurrentYear": -2.3488371, "fiftyDayAverageChange": -0.04408002, "fiftyDayAverageChangePercent": -0.041818477, "twoHundredDayAverageChange": -0.13318503, "twoHundredDayAverageChangePercent": -0.11650348, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]